Chicago Equity Partners’s Medicines Co MDCO Stock Holding History

Chicago Equity Partners’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-8,565	Closed	-$728K	–	946
2019 Q4	$728K	Sell	8,565 -31,580	-79%	-$2.11M	0.04%	546
2019 Q3	$2.01M	Sell	40,145 -600	-1%	-$23.9K	0.1%	316
2019 Q2	$1.49M	Sell	40,745 -19,065	-32%	-$622K	0.07%	412
2019 Q1	$1.67M	Buy	59,810 +1,090	+2%	+$25.7K	0.06%	388
2018 Q4	$1.12M	Buy	+58,720	New	+$1.37M	0.05%	468

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Chicago Equity Partners's MDCO Position: Q1 2020 in Review

Chicago Equity Partners sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 8,565 shares — an estimated $728K sold.

Chicago Equity Partners first reported a position in MDCO in Q4 2018 and held it in 5 quarters. The position peaked at $2.01M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Chicago Equity Partners reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Chicago Equity Partners sold 8,565 Medicines Co shares in Q1 2020, an estimated $728K.
Chicago Equity Partners first reported a position in Medicines Co in Q4 2018 and held it in 5 quarters.
Chicago Equity Partners's Medicines Co position peaked at $2.01M in Q3 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.